VIA
ONC

Virtus Investment Advisers’s BeOne Medicines Ltd ONC Stock Holding History

Virtus Investment Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
4,397
+1,751
+66% +$516K 0.29% 170
2026
Q1 		$786K Buy
2,646
+505
+24% +$163K 0.22% 164
2025
Q4 		$650K Buy
2,141
+534
+33% +$175K 0.18% 203
2025
Q3 		$548K Hold
1,607
– – 0.16% 194
2025
Q2 		$389K Sell
1,607
-382
-19% -$93.7K 0.13% 229
2025
Q1 		$541K Buy
+1,989
New +$465K 0.15% 196

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtus Investment Advisers's ONC Position: Q2 2026 in Review

Virtus Investment Advisers increased its BeOne Medicines Ltd (ONC) stake by 66% in Q2 2026, buying an estimated $516K and bringing the position to 4,397 shares worth $1.25M. The position accounts for 0.29% of the portfolio, ranked #170.

Virtus Investment Advisers first reported a position in ONC in Q1 2025 and has held it in 6 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Virtus Investment Advisers held 4,397 shares of BeOne Medicines Ltd worth $1.25M as of Q2 2026.
  • Virtus Investment Advisers bought 1,751 BeOne Medicines Ltd shares in Q2 2026, an estimated $516K.
  • BeOne Medicines Ltd made up 0.29% of Virtus Investment Advisers's portfolio in Q2 2026, its #170 holding.
  • Virtus Investment Advisers first reported a position in BeOne Medicines Ltd in Q1 2025 and has held it in 6 quarters since.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.